Research & Development

青娱乐亚洲领先的青青草91自拍视频网站超碰福利久久精品视频久草在线观看拍拍贷Q2营收及净利润同比双双增长 撮合额创新高


  思炫一臉呆滯地說︰“吳文豪確實不是他殺的。”   李墨點了點頭︰“基本上是吧。周末下午我老婆要上班,我沒事兒做,吳文豪單身,也無聊得很,而我倆又都喜歡玩CS,所以最近半年我們基本每周六下午都留在公司玩CS。”青娱乐   “鏡神。”亚洲领先的青青草91自拍视频网站   福小生頭甩得像撥浪鼓道︰“他屋里都是古董瓷器,我怕踫碎了他賴上我。”   霍奇俠點了點頭,問道︰“王冬的妻子就是凶手?”超碰福利久久精品视频久草在线观看   孫寡婦是一個寡婦,一個美麗動人的寡婦。福小生轉了個彎一指說︰“喏,靠在窗邊的就是她。”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo